Trial Profile
Pharmacodynamic Interactions Between Remifentanil and Dexmedetomidine (PIRAD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Remifentanil (Primary)
- Indications Anaesthesia; Cancer pain; Pain; Sedation; Subarachnoid haemorrhage
- Focus Pharmacodynamics
- Acronyms PIRAD
- 10 Jul 2020 Results published in the British Journal of Anaesthesia
- 10 Oct 2018 Status changed from recruiting to completed.
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.